Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nexus Surgical and MedicareBOM:538874 -4.06%88 ROC (Joel Greenblatt) % is 446.29% as of Jun. 2026, which is 141% above its 10-year median of 185.35. GuruFocus rates BOM:538874 with a GF Score™ of 88/100 and a GF Value™ of ₹30.60 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 120 Medical Distribution companies, Nexus Surgical and Medicare ranks better than 95.83% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Nexus Surgical and Medicare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 446.29%.
The historical rank and industry rank for Nexus Surgical and Medicare's ROC (Joel Greenblatt) % or its related term are showing as below:
BOM:538874'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -5.84 Med: 185.35 Max: 2348.72
Current: 144.58
During the past 13 years, Nexus Surgical and Medicare's highest ROC (Joel Greenblatt) % was 2348.72%. The lowest was -5.84%. And the median was 185.35%.
BOM:538874's ROC (Joel Greenblatt) % is ranked better than 95.83% of 120
companies
in the Medical Distribution industry
Industry Median: 15.92
vs BOM:538874: 144.58
Nexus Surgical and Medicare (BOM:538874) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nexus Surgical and Medicare ROC (Joel Greenblatt) % Chart
BOM:538874 vs MCK, COR, CAH: ROC (Joel Greenblatt) % Comparison
For the Medical Distribution subindustry, Nexus Surgical and Medicare's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexus Surgical and Medicare ROC (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Nexus Surgical and Medicare's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Nexus Surgical and Medicare's ROC (Joel Greenblatt) % falls into.
Nexus Surgical and Medicare ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 446.29% mean?
Nexus Surgical and Medicare (BOM:538874) has a ROC (Joel Greenblatt) % of 446.29% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Nexus Surgical and Medicare and its competitors. This is 141% above median its historical median of 185.35. According to the industry distribution chart, Nexus Surgical and Medicare ranks #5 out of 120 companies in the Medical Distribution industry, placing it in the top 4.2%.
Is Nexus Surgical and Medicare's ROC (Joel Greenblatt) % too high?
Nexus Surgical and Medicare's current ROC (Joel Greenblatt) % of 446.29% is 141% above median its 10-year median of 185.35. The Medical Distribution industry median ROC (Joel Greenblatt) % is 15.92. Nexus Surgical and Medicare's value of 446.29% is 2703.3% above this industry median. Based on the distribution chart, Nexus Surgical and Medicare ranks #5 out of 120 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Nexus Surgical and Medicare has a GF Score™ of 88/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nexus Surgical and Medicare's ROC (Joel Greenblatt) % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Nexus Surgical and Medicare ranks #5 out of 120 companies for ROC (Joel Greenblatt) %. This places Nexus Surgical and Medicare in the top 4% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 15.92. Nexus Surgical and Medicare's value of 446.29% is 2703.3% above this benchmark. While the company's 10-year median is 185.35 vs. the industry median of 15.92, Nexus Surgical and Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Distribution company?
The median ROC (Joel Greenblatt) % among Medical Distribution companies is 15.92, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nexus Surgical and Medicare's current ROC (Joel Greenblatt) % of 446.29% is 2703.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Nexus Surgical and Medicare and its competitors. For the Medical Distribution industry, the median ROC (Joel Greenblatt) % is 15.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexus Surgical and Medicare's current ROC (Joel Greenblatt) % is 446.29%, which is 141% above median its own 10-year median of 185.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexus Surgical and Medicare stock overvalued right now?
Based on GuruFocus' analysis, Nexus Surgical and Medicare (BOM:538874) is currently considered Possible Value Trap. The stock's GF Value™ is ₹30.60, compared to a current price of ₹20.80 — trading 32% below its estimated fair value. The current ROC (Joel Greenblatt) % is 446.29%, which is 141% above median its 10-year median of 185.35 and 2703.3% above the Medical Distribution industry median of 15.92. Nexus Surgical and Medicare's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Nexus Surgical and Medicare (BOM:538874), the current ROC (Joel Greenblatt) % is 446.29% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nexus Surgical and Medicare (BOM:538874) Overvalued in 2026?
Based on GuruFocus' analysis, Nexus Surgical and Medicare stock appears to be undervalued.
The current stock price of ₹20.80 is trading 32% below its estimated GF Value™ of ₹30.60.
GuruFocus considers Nexus Surgical and Medicare to be Possible Value Trap.
Key valuation signals for BOM:538874:
ROC (Joel Greenblatt) %: 446.29% (141% above median its 10-year median of 185.35)
GF Value™: ₹30.60 vs. price of ₹20.80 (32% below fair value)
Industry Position: 2703.3% above the Medical Distribution median (#5 of 120)
No single metric tells the full story. See the BOM:538874 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nexus Surgical and Medicare Ltd is involved in Importing and Marketing Quality Surgical and Pharmaceutical Products at an Economical Price. The Company is a wholesale dealer dealing in various sizes of disposal syringes (with and without needles) and pouches of various sizes used for the storage of sterilized equipment and materials. It operates in the segment of trading activities.
88GF Score
Get the complete analysis for BOM:538874
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:538874 has been successfully added to your 
